![Lisa Bollinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lisa Bollinger
Technik-/Wissenschafts-/F&E-Leiter bei
POLARYX THERAPEUTICS, INC.
Vermögen: 1 171 $ am 31.05.2026
Profil
Lisa L.
Bollinger is an Independent Director at Apogee Therapeutics, Inc. since 2024 and Chief Medical Officer at Polaryx Therapeutics, Inc. starting in 2025.
Former roles include Associate Director-New Drug at the Center for Drug Evaluation & Research, Vice President-Global Regulatory Affairs, R&D at Amgen, Inc. from 2018 to 2021, and VP-Regulatory Affairs & Global Regulatory Affairs at Merck & Co., Inc. from 2021 to 2024.
Education includes a doctorate from Uniformed Services University of the Health Sciences and an undergraduate degree from the University of California.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.02.2026 | 358 ( 0 % ) | 1 171 $ | 31.05.2026 | |
| 09.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Lisa Bollinger
| Unternehmen | Position | Beginn |
|---|---|---|
| APOGEE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 28.05.2024 |
| POLARYX THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2025 |
Ehemalige bekannte Positionen von Lisa Bollinger
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK & CO., INC. | General Counsel | 01.05.2024 |
| AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2021 |
Center for Drug Evaluation & Research
 Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Corporate Officer/Principal | - |
Ausbildung von Lisa Bollinger
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
17
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Uniformed Services University of the Health Sciences
 Uniformed Services University of the Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Center for Drug Evaluation & Research
Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Government |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Polaryx Therapeutics, Inc.
 Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders | Commercial Services |
Apogee Therapeutics, Inc.
 Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
